CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
CM-1500device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05125848
NCT05125848N/ACompleted
CompareCT.gov

Clinical Evaluation of the CM-1500 During Hemodialysis

Zynex Monitoring Solutions·interventional·Posted Nov 18, 2021·Updated May 1, 2024

In Brief

A clinical study evaluating CM-1500 for Fluid Loss and Dialysis. Completed, enrolled 15 participants across 1 site.

Detailed Summary

The study is a prospective, single-arm, non-randomized, non-blinded, non-controlled, non-significant risk, single center study enrolling up to 20 subjects consented to undergo a hemodialysis session as a part of their standard prescribed treatment plan. Subjects will consent to undergo non-invasive monitoring with the CM-1500 during three (3) separate sequential hemodialysis sessions.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFluid Loss, Dialysis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedNov 18, 2021
Enrollment StartNov 29, 2021
Primary CompletionMar 4, 2022
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 4.6 years ago

Interventions

CM-1500device

The CM-1500 is a U.S. FDA cleared non-invasive monitoring device that simultaneously monitors five (5) parameters of a patient's body. A combination of these parameters is represented by a single number known as the Relative Index value. This value is indicative of relative changes in fluid volume.